Similar Papers

Paper Title
Journal
Date
Author
Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status.
Yuan Chen ... Chawnshang Chang
Oncotarget | VOL. 6
Yuan Chen, et. al.Yuan Chen ... Chawnshang Chang
18 Aug 2015
Expression and Proliferation-Promoting Role of Lymphoid Enhancer-Binding Factor 1 in Human Clear Cell Renal Carcinoma
Donghao Shang ... Yuting Liu
Cancer Investigation | VOL. 32
Donghao Shang, et. al.Donghao Shang ... Yuting Liu
04 Jun 2014
The expression of NF-κB and COX-2 protein in renal cell carcinoma and its clinical value
...
Cancer Research and Clinic | VOL. 20
, et. al. ...
28 Jun 2008
RASSF1A promoter methylation correlates development, progression, and poor cancer-specific survival of renal cell carcinoma: trial sequential analysis.
Qianfeng Zhuang ... Jie Shen
OncoTargets and therapy | VOL. 12
Qianfeng Zhuang, et. al.Qianfeng Zhuang ... Jie Shen
01 Dec 2018
View more papers

More From: Oncogene

Paper Title
Journal
Date
Author
Correction: Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy.
Sonali Sinha ... Reena Rao
Oncogene | VOL. -
Sonali Sinha, et. al.Sonali Sinha ... Reena Rao
27 Jan 2025
Correction: Loss-of-function mutations of SOX17 lead to YAP/TEAD activation-dependent malignant transformation in endometrial cancer.
Mengfei Wang ... Xiaoping Wan
Oncogene | VOL. -
Mengfei Wang, et. al.Mengfei Wang ... Xiaoping Wan
27 Jan 2025
The protection of UCK2 protein stability by GART maintains pyrimidine salvage synthesis for HCC growth under glucose limitation.
Nannan Sha ... Qin Zhao
Oncogene | VOL. -
Nannan Sha, et. al.Nannan Sha ... Qin Zhao
26 Jan 2025
S100A8/A9 innate immune signaling as a distinct mechanism driving progression of smoking-related breast cancers.
Samson Mugisha ... Jay S Desgrosellier
Oncogene | VOL. -
Samson Mugisha, et. al.Samson Mugisha ... Jay S Desgrosellier
25 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.